Julius Knowles

Julius Knowles is currently an Independent Director at Keros Therapeutics, Inc. since 2016.
Julius is also a Director at Abcuro, Inc. and Paros Bio, Inc. Julius serves as a Partner at Mass General Brigham Ventures LLC and Partners Innovation Fund LLC since 2014, and is a Partner at Partners Innovation Fund II LP.
Formerly, Julius was Chief Executive Officer at X-Body, Inc. from 2012 to 2014.
Julius was a Director at Aurigene Oncology Ltd. and Rome Therapeutics, Inc. Julius was Director-Research & Development Planning at Vertex Pharmaceuticals, Inc. from 1993 to 1999.
Julius was Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. from 2006 to 2012.
Julius was President at Novalar Pharmaceuticals, Inc. from 2002 to 2006.
Julius was Vice President-Business Development at SGX Pharmaceuticals, Inc. from 1999 to 2001 and at Novacea, Inc. from 2001 to 2002.
Julius earned an MBA from the University of Pennsylvania in 1993, completed graduate studies at the University of California, Berkeley in 1987, and completed undergraduate studies at Carleton College in 1985.